Laronix Secures $3.2 Million Grant from the Australian Government to Bring its AI-Powered Voice Technology to the Market
BRISBANE, Australia, Nov. 12, 2025 /PRNewswire/ — Laronix, (“Laronix” or the “Company”), a commercial-stage medical technology (MedTech) company and an industry-leading innovator in voice restoration technologies, today announced that it has been awarded AUD $3.2 million (approximately USD $2.1 million) in non-dilutive funding from the Australian Government’s Industry Growth Program (IGP 2025).
